Norway

Welcome to the Norwegian page of the ESCP website

This page contains details about Colorectal Surgery and research in Norway. The https://www.kolorektal.no/. Norwegian Society for Colorectal Surgery is a part of the Norwegian Association of Gastrointestinal Surgery, a suborganization of the Norwegian Medical Association (http://www.legeforeningen.no/.) Also, information about the Norwegian Colorectal Cancer Registry is presented HERE: https://tinyurl.com/2p8aetpk

If any member of the ESCP wishes to contact me on any matter, please do not hesitate to contact me via email at This email address is being protected from spambots. You need JavaScript enabled to view it. or at phone +47 92624077.

Kind regards

Bjorn Steinar Nedreboe

Population: 5 million
ESCP Members: 25
Colorectal Surgeons: Approximately 120
Society: Norwegian Society of Colorectal Surgery, Norwegian Association for Gastrointestinal Surgery

ESCP Representative Name: Bjorn Steinar Nedreboe
National Examination: None

Achievements

Relevant achievements in Norway include:

1994: Establishment of the Norwegian Rectal Cancer Registry

2007: Establishment of the Norwegian Colorectal Cancer Registry

2010: New evidence-based government endorsed national guidelines for colorectal cancer

2002-2020: Gradual improvement nationwide of 5 year relative survival in rectal cancer patients, currently at 73%, and for colon cancer at 72%

From 2012 New national database for liver met. surgery

2015 Establishing of LapcoNor, a regional (South East Health Authority) education program for laparoscopic colorectal cancer surgery in cooperation with the Lapco program in UK

From 2016 National registry for complications after GI surgery; NORGAST

2016 Establishing of the new Norwegian Society for Colorectal Surgery

Current Research

New National trial: "Watch and Wait" in patients with complete clinical response (CCR) after neo-adjuvant chemoradiotherapy for primary locally advanced rectal cancer. Protocol finished by Des. 2016. Start of inclusion January - February 2018, is stopped due to high number of metastases.